Global: Diverse: Thought Leading
Izy Capital brings a multi-disciplined team of thought leaders to work with the best global entrepreneurial minds. Always on hand, we adopt a long term partnership approach both in venture and advisory. 24 x 7, everywhere.
Meet The Team
David Rees (Deceased)
Until August 2020 David was a General Partner of IZY Capital. A Fellow of the Institute of Chartered Accountants, David had spent the last 25 years as a technology analyst, strategist, investment banker and more latterly investor and entrepreneur.
Joanne Hackett PhD
Joanne leads the Healthcare Practice where she works with, incubates and grows the next generation of world leading innovators. Joanne is a clinical academic, entrepreneur, investor and a strategic, creative visionary with global experience spanning successful start-ups to Fortune 500 companies.
Thomas is a serial entrepreneur with multiple exits across the D2C, Blockchain, Platform and Enterprise Supply Chain verticals . Thomas leads origination in the US and Canada’ and is also responsible for scaling strategies for the Izy portfolio.
Paolo is a Managing Director at IZY Capital. During a 24-year career in Capital Markets and Investment Banking, much of this time was spent as a Head of Investment Research and as a CEO. With a passion for Angel investing, Paolo has more recently been a mentor and advisor to start-ups and scaling businesses.
Sub Sector: Hardware
Izy advised Drone Evolution on a recent equity seed round from a syndicate of strategic angel investors. The management team has a proven track record in the industry, having formally run the Drone division for a major facilities management team. Capital is being used to develop a range of commercial applications for the commercial aviation and security markets.
Sub Sector: Software/Clinical Support
TaperMD is a clinical decision support platform pioneered by some of the leading experts in medication management and polypharmacology. Izy is working with the team to develop the platform and assess the market opportunity. The product is currently in trials on three continents and will move to commercialisation in 2019.
Sub Sector: Artificial Intelligence
BIOS is fast becoming a global leader in harnessing the power of AI to decode and encode the signals from brain to body. The Founders, Emil and Oli, have extensive knowledge in computational neuroscience, machine learning and bioengineering. The company has built the world’s largest neural biomarker discovery dataset, uniquely enabling 3rd parties to create neural therapies using their platform.
Sub Sector: Healthtech
IQVIA™ (NYSE:IQV) and Genomics England are collaborating to develop a platform that will connect clinical and de-identified genomics data to accelerate treatment advancements for patients. This alliance will enable faster and more efficient drug research, more robust evidence to support treatment value, and greater access to personalised medicines.
Sub Sector: Healthcare
Circle Health, the independent hospital group, and BMI Healthcare, the UK’s leading independent hospital operator, recently announced that Circle Health has agreed to acquire BMI Healthcare to deliver a new generation of best-in-class hospitals. BMI Healthcare manages a network of hospitals and clinics throughout the UK, with over two million patient visits per year.
Sub Sector: Healthtech
In 2018, as part of a new focus on advancing the treatment of lung cancer, BTG invested $20m in Veran Medical Technologies, Inc. BTG is a global healthcare company focused on Interventional Medicine and Veran is a privately held medical device company whose mission is to empower physicians to diagnose cancer earlier and to enable precision therapy to save lives.